Solange Peters
索朗日·彼得斯
MD, PhD
Head of Medical Oncology, Professor of Oncology肿瘤内科主任，肿瘤学教授
👥Biography 个人简介
Prof. Solange Peters is one of Europe's most influential thoracic oncologists and a past ESMO President. Her work on perioperative pembrolizumab in resectable NSCLC and neoadjuvant/adjuvant immunotherapy has fundamentally changed the surgical lung cancer landscape, and she chairs major ESMO guideline committees.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Perioperative Immunotherapy & ESMO Leadership
Led and co-authored pivotal studies on perioperative pembrolizumab for resectable NSCLC and served as ESMO President, shaping European lung cancer immunotherapy guidelines and consensus recommendations.
Representative Works 代表性著作
Pembrolizumab versus placebo as neoadjuvant/adjuvant therapy for early-stage NSCLC (KEYNOTE-671)
New England Journal of Medicine (2023)
Phase III trial demonstrating EFS and OS benefit with perioperative pembrolizumab, establishing a new standard of care for resectable stage II–IIIB NSCLC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 索朗日·彼得斯 的研究动态
Follow Solange Peters's research updates
留下邮箱，当我们发布与 Solange Peters（Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment